Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Medicine for treating chronic obstructive pulmonary disease in stable phase

A stable COPD technology, applied in drug combination, drug delivery, pharmaceutical formulations, etc., can solve problems such as lung infection, pulmonary insufficiency, loss of confidence in treatment, etc., and achieve the effect of relieving irritation and inhibiting skin allergic antibodies

Inactive Publication Date: 2016-01-20
刘涛
View PDF2 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, because ambroxol is only a phlegm-reducing drug and has no antitussive effect, patients cannot obtain curative effect in a short period of time, leading to loss of confidence in treatment or blindly seeking antitussive drugs, and the use of antitussive drugs will cause cough reflex suppression Retention of bronchial secretions leads to hypoventilation and even segmental atelectasis, leading to lung infection

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0028] Example 1, the weight ratio of raw materials: papaya 20g, rutabaga 12g, Yaluochun 12g, mountain cucumber 15g, cliff ginger 15g, wintergreen 15g, camphor 15g, stone flower 20g, saffron 15g, chicken head rice 15g, flax seed 12g, ghost grass 2g.

[0029] The preparation method of Example 1 is: mix papaya, wintergreen, rutabaga, chicken head rice, yarrow, mountain cucumber, cliff ginger, camphor, stone flower, sala seed, ghost grass, and flax seeds, add water and fry Boil, take the filtrate after 30 minutes, add water to the dregs and continue to decoct for 20 minutes, then take the filtrate, combine the two filtrates, and then filter with two layers of gauze. Add 95% ethanol once to make the solution ethanol concentration reach 75%, airtightly stand for 48h, filter, remove ethanol from the filtrate, use G 4 Filter through a vertically fused glass funnel until clear, sterilize at 100°C for 30 minutes, and store.

Embodiment 2

[0030] Embodiment 2, raw material drug weight ratio: 10 parts of papaya, 3 parts of rutabaga, 3 parts of Yaluo Chun, 12 parts of mountain cucumber, 12 parts of yajiang, 12 parts of wintergreen, 12 parts of camphor, 10 parts of rock flower, 12 parts of sala seeds, 12 parts of chicken head rice, 3 parts of flax seeds, and 1 part of ghost grass.

Embodiment 3

[0031] Embodiment 3, raw material drug weight ratio: 20 parts of papaya, 12 parts of rutabaga, 12 parts of Yaluochun, 15 parts of mountain cucumber, 15 parts of Yajiang, 15 parts of wintergreen, 15 parts of camphor, 20 parts of stone flower, 15 parts of sala seeds, 15 parts of chicken head rice, 12 parts of flax seeds, 2 parts of ghost grass.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicine for treating chronic obstructive pulmonary disease in the stable phase. The medicine is characterized by being prepared from the following medicinal raw materials: pawpaws, prinsepia uniflora batal, semen euryales, pyrola rotundifolia, cipadessa baccifera, tricyrtis root, pseudodrynaria coronans, cinnamomum camphora, parmelia tinctourium, semen aesculi, solanum lyratum thunb and semen lini. Clinical experiments prove that the medicine has the characteristics of good curative effect and relatively high safety when being used for treating chronic obstructive pulmonary disease, and is worthy of clinical application and popularization.

Description

technical field [0001] The invention relates to the field of traditional Chinese medicines, in particular to an aerosol inhalation medicine for the treatment of chronic obstructive pulmonary disease in stable phase. Background technique [0002] Chronic obstructive pulmonary disease (COPD), or chronic obstructive pulmonary disease (COPD), is characterized by airflow limitation that is not fully reversible. The most common symptoms of COPD are cough and sputum production. Long-term, repeated and gradually aggravating cough is the prominent manifestation of this disease. The course of COPD can be divided into acute exacerbation phase and stable phase. The acute exacerbation stage of COPD is often accompanied by inflammatory manifestations such as fever, which requires hospitalization, while the stable stage is generally only accompanied by symptoms such as cough, sputum, and shortness of breath, and there is basically no inflammatory reaction. At present, the clinical treatm...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/896A61K9/72A61K9/12A61P11/00A61P11/14
Inventor 刘涛
Owner 刘涛
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com